ARTLW Projected Dividend Yield
Wt Pur Com Exp 06/25/2024 (New)/Artelo Biosciences Inc ( NASDAQ : ARTLW )Artelo Biosciences is a clinical stage biopharmaceutical company focused on developing and commercializing treatments intended to modulate endogenous signalling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network throughout the body. Co. is developing a G protein-coupled receptor targeting synthetic small molecule program, ART27.13, as a treatment for anorexia associated with cancer; ART26.12, which a small molecule inhibitor of Fatty Acid Binding Protein 5, for cancer therapeutic and anxiety-related disorder, including post-traumatic stress disorder; and ART12.11, a solid-state composition of cannabidiol. 20 YEAR PERFORMANCE RESULTS |
ARTLW Dividend History Detail ARTLW Dividend News ARTLW Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |